BioHealth News Archive
Steve Case to lead off new Anchor Ventures speaker series – Maryland Daily Record
AOL co-founder Steve Case will be the inaugural speaker for Anchor Ventures’s speaker series. Anchor Ventures is a collaboration between University of Maryland Ventures…
Read More
Paragon Bioservices Expands Production Campus in Baltimore, Maryland – Area Development
Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization with proven expertise in gene therapy and next-generation vaccines, is expanding a…
Read More
Just Released! REDI Annual Report Highlights 2017 Accomplishments
2017 marked continued growth for Rockville Economic Development, Inc. (REDI) and the Maryland Women's Business Center (MWBC). We are pleased to highlight our many…
Read More
Could this new incubator nurture the next big thing in life sciences? – Cambridge News
Cambridge's up and coming life sciences firms will be able to benefit from the expertise of some of the biggest names in the sector…
Read More
Pursuing breakthroughs in cancer-drug development | McKinsey & Company
The pharmaceutical industry continues to pursue the discovery of medicines for cancer patients with unprecedented rigor. Over the past several years, three major trends…
Read More
Paragon Bioservices Bolsters Leadership Ranks with Executive Appointments, New Vice President Hires
Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, announces today…
Read More
QIAGEN Receives FDA Clearance for JAK2 Diagnostic Test – Technology Networks
QIAGEN announced that it has received clearance for its ipsogen JAK2 RGQ PCR Kit (ipsogen JAK2 assay) from the U.S. Food and Drug Administration…
Read More
Sanofi to Acquire Biogen Spin-Off in $11.6-Billion Deal | BioPharm International
On Jan. 22, 2018, Sanofi announce that it has entered into a definitive agreement to acquire all outstanding shares of Bioverativ, the hemophilia and…
Read More
New bio-incubator and life-science accelerator capability launches at Babraham – Cambridge Network
Accelerate@Babraham is designed to support the earliest stages of new life-science ventures, by providing easy-access laboratory and office space, (the ‘bio-incubator’) together with supporting…
Read More
ETC’S ACCELERATE BALTIMORE ANNOUNCES APPLICATIONS ARE OPEN FOR THE SEVENTH YEAR OF ITS SEED STAGE ACCELERATOR — Accelerate Baltimore
The ETC (Emerging Technology Centers), Baltimore City’s award-winning technology and innovation centers, announces the Accelerate Baltimore (AB) program will run for its seventh consecutive…
Read More
Startups: One Entrepreneur’s View of Balancing Passion with Practicality | UM Ventures
Richard Hughen’s first entrepreneurial experience was as Managing Director at e-learning startup LearnWare, where he says his “addiction” to startups began in earnest. The…
Read More
California Life Sciences Association Applauds Confirmation of Alex Azar as HHS Secretary – Business Wire
California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, today commended the U.S. Senate’s confirmation of Alex M. Azar, II…
Read More
Paragon Bioservices aims to create 200 jobs with Maryland expansion – Technical.ly Baltimore
Paragon Bioservices has plans to expand to new space over the next two years to help companies develop and manufacture biopharmaceuticals. {iframe}https://technical.ly/baltimore/2018/01/23/paragon-bioservices-aims-create-300-jobs-maryland-expansion/{/iframe}
Read More
Johns Hopkins U creates new test to screen for 8 cancers – WBFF
Researchers with the Johns Hopkins University School of Medicine developed a new blood test able to screen for eight types of cancers. {iframe}http://foxbaltimore.com/news/local/johns-hopkins-u-creates-new-test-to-screen-for-8-cancers{/iframe}
Read More
Regenxbio (RGNX) Enters Strategic Partnership with FUJIFILM Diosynth Biotechnologies
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary…
Read More